Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-036219
Filing Date
2019-06-11
Accepted
2019-06-11 18:36:55
Documents
1
Period of Report
2019-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4095
  Complete submission text file 0001209191-19-036219.txt   5422
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Daniel Thomas O (Reporting) CIK: 0001538894 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38796 | Film No.: 19892107

Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Issuer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations